Circulation, Vol 69, 382-390, Copyright © 1984 by American Heart Association
J Urquhart, RE Patterson, SL Bacharach, MV Green, EH Speir, R Aamodt and SE Epstein
The calcium channel-blocking drugs verapamil, diltiazem, and nifedipine are
being used with increasing frequency in patients with angina pectoris due
to coronary artery disease. Although each of these agents possesses
negative inotropic potential, their relative effects on myocardial function
in relation to their vasodilator potencies are unknown. We understood to
study this in 20 conscious dogs that had partial occlusions of their
circumflex coronary arteries during therapy with placebo, verapamil,
nifedipine, or diltiazem. Myocardial blood flow was measured by use of
microspheres, and left ventricular function was measured by radionuclide
angiography. Drug effects were compared at doses causing equal decreases in
mean arterial pressure and coronary vascular resistance of nonischemic
myocardium. Global ejection fraction and ejection fraction of the ischemic
region were significantly decreased by verapamil (p less than .01) and
increased by nifedipine (p less than .001); diltiazem caused no significant
changes. Verapamil significantly increased peak diastolic filling rate (p
less than .001); nifedipine also increased diastolic filling rate, but only
at doses that markedly decreased mean arterial pressure and coronary
vascular resistance. The effect of diltiazem on diastolic filling rate was
not significantly different than placebo. For doses causing an equal
decrease in mean arterial pressure, verapamil decreased heart rate (p less
than .001), and diltiazem and nifedipine increased heart rate (p less than
.001). We conclude that the relative potencies of these three calcium
channel blocking agents on left ventricular systolic and diastolic function
during myocardial ischemia are different when compared with their relative
vasodilator potencies. These differences may have important clinical
implications.
ARTICLES
Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs
This article has been cited by other articles:
![]() |
L. M. Riou, C. Ghezzi, G. Vanzetto, A. Broisat, J.-P. Mathieu, R. Bontron, R. Pasqualini, and D. Fagret Verapamil Does Not Inhibit 99mTcN-NOET Uptake In Situ in Normal or Ischemic Canine Myocardium J. Nucl. Med., June 1, 2003; 44(6): 981 - 987. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |